• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球视野。

The global view.

机构信息

Pulmonary Circulation Unit, Pulmonary Division, Heart Institute, University of São Paulo Medical School, São Paulo, Brazil.

出版信息

Curr Opin Pulm Med. 2019 Sep;25(5):391-397. doi: 10.1097/MCP.0000000000000603.

DOI:10.1097/MCP.0000000000000603
PMID:31365371
Abstract

PURPOSE OF REVIEW

To understand the global distribution of different forms of pulmonary hypertension.

RECENT FINDINGS

Different registries have explored the epidemiological characteristics of pulmonary hypertension. Interestingly, there is a clear difference in the prevalence of different forms of pulmonary hypertension in developed regions in comparison with less developed countries. This finding suggests not only that extrapolation of data should be avoided but also that the known prevalence of pulmonary hypertension might be underestimated.

SUMMARY

Pulmonary hypertension might be more prevalent than what is currently believed. Specific forms of pulmonary hypertension distributed worldwide might characterize an unrecognized burden that still have to be properly approached. This highlights the heterogeneity of pulmonary hypertension around the world. It is clear that more epidemiological data are still needed as well as studies addressing management alternatives in these specific regions.

摘要

目的综述

了解不同形式肺动脉高压的全球分布。

最近发现

不同的登记处已经探讨了肺动脉高压的流行病学特征。有趣的是,在发达国家和欠发达国家之间,不同形式肺动脉高压的患病率存在明显差异。这一发现不仅表明不应进行数据外推,而且还表明肺动脉高压的已知患病率可能被低估。

总结

肺动脉高压的患病率可能比目前认为的要高。分布在世界各地的特定形式的肺动脉高压可能构成了尚未得到妥善处理的、尚未被认识到的负担。这突出了全球肺动脉高压的异质性。显然,仍然需要更多的流行病学数据,以及在这些特定地区研究管理替代方案的研究。

相似文献

1
The global view.全球视野。
Curr Opin Pulm Med. 2019 Sep;25(5):391-397. doi: 10.1097/MCP.0000000000000603.
2
World Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology.世界卫生组织第一组肺动脉高压:流行病学与病理生理学
Cardiol Clin. 2016 Aug;34(3):363-74. doi: 10.1016/j.ccl.2016.04.001.
3
Group 5 Pulmonary Hypertension: The Orphan's Orphan Disease.第5组肺动脉高压:孤儿病中的孤儿病。
Cardiol Clin. 2016 Aug;34(3):443-9. doi: 10.1016/j.ccl.2016.04.004.
4
Current Trends and Future Perspectives in the Treatment of Pulmonary Hypertension: WHO Group II-V.肺动脉高压治疗的现状和未来趋势:WHO 组 II-V 类。
Curr Probl Cardiol. 2018 May;43(5):217-231. doi: 10.1016/j.cpcardiol.2017.10.003. Epub 2017 Oct 31.
5
Can pulmonary arterial hypertension be diagnosed by an elevated pulmonary capillary wedge pressure outside of the guideline criteria?肺动脉高压能否在指南标准之外通过升高的肺毛细血管楔压来诊断?
Chest. 2011 Sep;140(3):828-829. doi: 10.1378/chest.11-0616.
6
Group 2 Pulmonary Hypertension: Pulmonary Venous Hypertension: Epidemiology and Pathophysiology.第2组肺动脉高压:肺静脉高压:流行病学与病理生理学
Cardiol Clin. 2016 Aug;34(3):401-11. doi: 10.1016/j.ccl.2016.04.010.
7
Foreword.前言。
Curr Probl Cardiol. 2018 May;43(5):188. doi: 10.1016/j.cpcardiol.2018.03.001.
8
Definition, epidemiology and registries of pulmonary hypertension.肺动脉高压的定义、流行病学及登记系统
Heart Fail Rev. 2016 May;21(3):223-8. doi: 10.1007/s10741-015-9510-y.
9
The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.美国肺动脉高压患者的变化情况:REVEAL 与历史和非美国当代注册研究的不同之处。
Chest. 2011 Jan;139(1):128-37. doi: 10.1378/chest.10-0075. Epub 2010 Jun 17.
10
Prevalence of pulmonary hypertension in patients with chronic kidney disease without dialysis: a meta-analysis.未透析慢性肾脏病患者肺动脉高压的患病率:一项荟萃分析。
Int Urol Nephrol. 2018 Aug;50(8):1497-1504. doi: 10.1007/s11255-018-1853-6. Epub 2018 Mar 26.

引用本文的文献

1
Risk factors for microalbuminuria in adult Tibetan patients with high-altitude pulmonary hypertension: a cross-sectional study.成年藏族高原肺动脉高压患者微量白蛋白尿的危险因素:一项横断面研究
Cardiovasc Diagn Ther. 2023 Apr 28;13(2):336-344. doi: 10.21037/cdt-22-385. Epub 2023 Mar 29.
2
Prevalence, incidence, and survival of pulmonary arterial hypertension: A systematic review for the global burden of disease 2020 study.肺动脉高压的患病率、发病率和生存率:2020年全球疾病负担研究的系统评价
Pulm Circ. 2022 Jan 18;12(1):e12020. doi: 10.1002/pul2.12020. eCollection 2022 Jan.
3
Update on the Treatment of Pulmonary Arterial Hypertension.
肺动脉高压治疗进展。
Arq Bras Cardiol. 2021 Oct;117(4):750-764. doi: 10.36660/abc.20200702.